La biologie des carcinomes nasopharyngés en 2001: mise à jour et perspectives

Ablashi, 1997, Epstein-Barr virus and Kaposi's sarcoma Herpesvirus/Human Herpesvirus 8 Agathanggelou, 1995, Expression of Immune Regulatory Molecules in Epstein-Barr Virus-Associated Nasopharyngeal Carcinomas with Prominent Lymphoid Stroma. Evidence for a Functional Interaction between Epithelial Tumor Cells and Infiltrating Lymphoid Cells, Am J Pathol, 147, 1152 Busson, 1987, Epstein-Barr vims-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 α, Proc Natl Acad Sei USA, 84, 6262, 10.1073/pnas.84.17.6262 Busson, 1988, Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinoma tumors, Int J Cancer, 42, 599, 10.1002/ijc.2910420422 Busson, 1992, Consistent transcription of the Epstein-Barr vims LMP2 gene in nasopharyngeal carcinoma, J Virol, 66, 3257, 10.1128/JVI.66.5.3257-3262.1992 Cheung, 1999, Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus, Int J Cancer, 83, 121, 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F Decaussin, 2000, Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies, Cancer Res, 60, 5584 Devergne, 1996, Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr Virus LMP 1 domain important for B-lymphocy te transformation: role in NF-kB activation, Mol Cell Biol, 16, 7098, 10.1128/MCB.16.12.7098 Effert, 1992, Alterations of the p53 gene in nasopharyngeal carcinoma, J Virol, 66, 3768, 10.1128/JVI.66.6.3768-3775.1992 Fahraeus, 1988, Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma, Int J Cancer, 42, 329, 10.1002/ijc.2910420305 Ferradini, 1991, Cytotoxic potential despite impaired activation pathways in T-lymphocytes infiltrating nasopharyngeal carcinoma, Int J Cancer, 47, 362, 10.1002/ijc.2910470309 Fries, 1997, Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr vims, J Virol, 71, 2765, 10.1128/JVI.71.4.2765-2771.1997 Gulley, 1998, Nasopharyngeal carcinomas frequently lack the pl6/MTSl tumor suppressor protein but consistently express the retinoblastoma gene product, Am J Pathol, 152, 865 Henry, 2001, In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr vims strains, Int J Cancer, 91, 698, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1110>3.0.CO;2-2 Hu, 1996, Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma, Genes Chromosomes Cancer, 17, 118, 10.1002/(SICI)1098-2264(199610)17:2<118::AID-GCC7>3.0.CO;2-8 Huang, 1999, Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4 + T cells, Cancer Res, 59, 1599 Khabir, 2000, Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas, Clin Cancer Res, 6, 3932 Khanim, 1996, Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations, Blood, 88, 3491, 10.1182/blood.V88.9.3491.bloodjournal8893491 Klein, 1974, Direct evidence for the presence of Epstein-Barr vims DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx, Proc Natl Acad Sei USA, 71, 4737, 10.1073/pnas.71.12.4737 Komano, 1999, Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata, J Virol, 73, 9827, 10.1128/JVI.73.12.9827-9831.1999 Kripalani-Joshi, 1994, Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis, Int J Cancer, 56, 187, 10.1002/ijc.2910560207 Lo, 1996, Hypermethylation of the pl6 gene in nasopharyngeal carcinoma, Cancer Res, 56, 2721 Lo, 2000, High resolution allelotype of microdissected primary nasopharyngeal carcinoma, Cancer Res, 60, 3348 Lu, 1990, Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region, Nature, 346, 470, 10.1038/346470a0 Nicholls, 1997, The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr vims shows geographical variation reminiscent of Burkitt's lymphoma, J Pathol, 183, 164, 10.1002/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J Niedobitek, 1996, Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma, Semin Cancer Biol, 7, 165, 10.1006/scbi.1996.0023 Ooi, 1997, Association between microsatellites within the human MHC and nasopharyngeal carcinoma, Int J Cancer, 74, 229, 10.1002/(SICI)1097-0215(19970422)74:2<229::AID-IJC16>3.0.CO;2-8 Patlimanathan, 1995, Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma, N Engl J Med, 333, 693, 10.1056/NEJM199509143331103 Sbih-Lamali, 1999, Control of apoptosis in epithelial NPC cells: opposite effects of CD95 and CD 40 stimulation, Cancer Res, 59, 924 Sellami, 2000 Sheen, 1999, Epstein-Barr virus-encoded latent membrane protein 1 co-expresses with epidermal growth factor receptor in nasopharyngeal carcinoma, Jpn J Cancer Res, 90, 1285, 10.1111/j.1349-7006.1999.tb00710.x Sun, 1999, Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors, Anticancer Res, 19, 919 Tang, 2001, A distinct espression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages, Hum Pathol, 32, 42, 10.1053/hupa.2001.20886 Tsai, 1999, Analysis of the expression of Fas-L in nasopharyngeal carcinoma tissues, Oral Oncol, 35, 421, 10.1016/S1368-8375(99)00016-0 Yu, 1986, Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study, Cancer Res, 46, 956 Xie, 2000, Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array, J Cancer Res Clin Oncol, 126, 400, 10.1007/PL00008488 Zur Hausen, 2000, Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene, Cancer Res, 60, 2745